Autohome is to make an investment in TTP Car Inc., an auction platform for used cars in China, through subscription of preferred shares in the capital of the company for an aggregate purchase price of US$168m.
Gracell Biotechnologies Inc., a Shangai, China-based clinical-stage biopharmaceutical company dedicated to developing cell therapies for the treatment of cancer, secured $100m in Series C funding.
Morningside Venture Capital, a Shangai, China-based investment firm, has changed its name to 5Y Capital.
Fourier Intelligence, a Shanghai, China-based rehabilitation robotic system provider, completed its RMB 100M Series C financing round.
Yuanfudao, a Beijing, China-based online education platform, closed a US$2.2 billion Series G1 and G2 financing.
Enzymaster, a global biotech company with locations in China, Germany and Singapore specialized in biocatalysis and enzyme engineering, closed a US$7.5M (CNY 50 Mio) Series B-1 funding.
China Creation Ventures, a Beijing, China-based venture capital firm, closed its second USD fund, at over $300m.
EdiGene, Inc., a Beijing, China-based developer of genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, completed an RMB 450 million (approximately USD 67 million) Series B financing.
InventisBio, a Shangai, China-based clinical stage biotech company dedicated to the research and development of innovative small molecule drugs, closed a $147m series D financing.
Entities controlled by Levo Chan, CEO of Tak Chun Group, are reportedly making a new offer for approx. 29.2% of the shares of Macau Legend Development Ltd. (SEHK Stock Code: 1680), a casino services and hotel company.
Biocytogen, a Chinese clinical stage company, completed its series D1 funding raising USD 142m.
ImmVira Group Company, a Chinese biotechnology company focused on the development of new generation oncolytic viruses as potential cancer therapeutics, signed US$10m Series B Plus strategic financing.
JD.com Inc, the large Chinese ecommerce retailer, reported very healthy revenue and earnings for the period April – June 2020.
Dreame Technology, a Beijing, China-based smart consumer technology company, raised nearly RMB 100 million (US$14.6m) in its Series B+ funding.
InxMed (Nanjing) Co., Ltd., a Nanjing, China-based clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, completed a Series A+ financing of approx. US$19m.